SCHEMBL5836093

SCHEMBL5836093

CCN(CC)c1ccc(NC(=O)C2(NC(=O)O)CCc3ccccc3C2)c(C)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 3/20 0.58
HTT P42858 3/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPT P10636 8/20 0.47
MAPK1 P28482 5/20 0.47
HCRTR1 O43613 1/20 0.47
GFER P55789 6/20 0.47
ALOX15 P16050 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
SMN1; SMN2 Q16637 3/20 0.45
CYP2C19 P33261 2/20 0.45
CYP1A2 P05177 1/20 0.45
POLB P06746 1/20 0.45
ALDH1A1 P00352 3/20 0.44
NPSR1 Q6W5P4 2/20 0.44
HSD17B10 Q99714 3/20 0.44
LMNA P02545 3/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835556 0.88 GHSR (0.77) GHSRHTTKDM4EMAPTMAPK1
SCHEMBL5835734 0.86 GHSR (0.74) GHSRMAPTHCRTR1GFERMEN1
SCHEMBL5834796 0.77 GHSR (0.82) GHSRKDM4EMAPTMAPK1HCRTR1
SCHEMBL5834813 0.75 GHSR (0.63) GHSRHTTKDM4EMAPTMAPK1
SCHEMBL5835587 0.75 GHSR (0.63) GHSRHTTKDM4EMAPTMAPK1
SCHEMBL5835928 0.75 GHSR (0.65) GHSRHTTKDM4EMAPTMAPK1
SCHEMBL5834854 0.74 GHSR (0.77) GHSRMAPTMAPK1MEN1KMT2A
SCHEMBL5835307 0.74 GHSR (0.77) GHSRKDM4EMAPTGFERMEN1
SCHEMBL5835050 0.73 GHSR (0.79) GHSRMAPTMAPK1HCRTR1GFER
SCHEMBL5834877 0.73 GHSR (0.59) GHSRMAPTMAPK1GFERMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators GPR119, GHSR, GIPR GHSR 2/4885HTT 784/4885KDM4E 2302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.